Pharmaceutical Excipients Market to Witness Comprehensive Growth by 2027

The global pharmaceutical excipients market was valued at US$ 6.9 Bn in 2018 and is projected to expand at a high CAGR from 2019 to 2027.

Wilmington, Delaware, United States, Transparency Market Research Inc. The global pharmaceutical excipients market was valued at US$ 6.9 Bn in 2018 and is projected to expand at a high CAGR from 2019 to 2027. In terms of volume, the global pharmaceutical excipients market was valued at 2,108,405 tons in 2018. Rise in adoption of orphan drugs, growing approvals of biosimilars, increase in focus on development of novel excipients, and changing regulatory scenario are expected to drive the global pharmaceutical excipients market.

Research & development in the field of pharmaceutical excipients is focused on the development of novel excipients, mainly of plant origin, owing to their advantages including their biodegradable nature, non-toxicity, biocompatibility, low cost, and ease of availability

Increasing approval of oral solid dosage formulations by the U.S. FDA, owing to the high patient preference for oral medications aids in the growth of the pharmaceutical excipients market.

Request Sample of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12662

Holistic Approach in Specialized Dosage Formulations Create Incremental Opportunities

  • The pharmaceutical excipients market is expected to expand at a CAGR of ~5% during the forecast period. However, there are certain challenges such as poor solubility of active pharmaceutical ingredients (APIs) in the formulation of oral solid dosage drugs. Hence, companies in the market for pharmaceutical excipients are increasing R&D in spray drying, lipid-based drug delivery, and multiparticulate systems to overcome the limitations of traditional approaches. This is evident since the oral formulation segment is predicted for exponential growth. The global pharmaceutical excipients market is projected to reach ~US$ 10.7 Bn by the end of 2027.
  • Pharmaceutical companies are capitalizing on the demand for specialized dosage forms such as pediatric/geriatric and controlled-release formulations. Since traditional solid tablets are hard to swallow, companies in the market for pharmaceutical excipients are using this opportunity with the full potential to meet consumer needs. They are increasing their production capabilities to develop innovative dosage forms such as orally disintegrating granules (ODGs), effervescent tablets, lozenges, and the likes that are designed to swallow easily.

Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=12662

Lipid Excipients and Polymers Overcome Issues in Drug Development

  • Companies in the pharmaceutical excipients market are developing excipients that improve the dissolution of APIs and enhance API permeability across the biological membrane in order to innovate in drug delivery. Likewise, lipid excipients are acquiring popularity as multifunctional excipients, since they fulfill the requirements in dose and formulation. Companies in the market for pharmaceutical excipients are increasing their production capacities to develop excipients that are suitable for low-temperature melt granulation and melt extrusion. As such, there is a growing demand for excipients that solubilize APIs in the gastric media and enhance lymphatic transport, which is desirable for drugs that are subject to hepatic elimination.
  • Innovative lipid excipients help disperse the drug in the lipid matrix, thus providing protection for drugs against the incidence of hydrolysis or oxidation for sensitive APIs. In order to achieve bioavailability, companies are adopting the approach of amorphous solid dispersions. This innovative approach is being combined with polymers, which contribute toward amorphous embedding and prevent recrystallization during storage.

Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=12662

Pharmaceutical Excipients: Market Segmentation

  • The global pharmaceutical excipients market has been segmented based on product, functionality, formulation, source, and region
  • In terms of product, the global pharmaceutical excipients market has been categorized into organic chemicals, inorganic chemicals, and others. The organic chemicals segment has been sub-segmented into carbohydrates, petrochemicals, oleochemicals, proteins, and others. The carbohydrates sub-segment has been further segmented into sugars, starch, and cellulose. The petrochemicals sub-segment has been further segmented into glycols, povidones, mineral hydrocarbons, acrylic polymers, and others. The oleochemicals sub-segment has been further segmented into fatty alcohols, mineral stearates, glycerin, and others. The inorganic chemicals segment has been further sub-segmented into calcium phosphate, calcium carbonate, calcium sulfate, halites, metallic oxides, and others
  • Based on functionality, the global pharmaceutical excipients market has been segregated into fillers & diluents, viscosity agents, coating agents, binders, disintegrants, flavoring agents & sweeteners, lubricants & glidants, colorants, preservatives, and others
  • Based on formulation, the global pharmaceutical excipients market has been further segmented into oral, topical, parenteral, and others. The oral segment dominated the global pharmaceutical excipients market in 2018 and it likely to maintain its dominance in the forecast period
  • Based on source, the global pharmaceutical excipients market has been divided into plant origin, animal origin, synthetic, and mineral origin

Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=12662

Pharmaceutical Excipients Market: Regional Segmentation

  • In terms of region, the global pharmaceutical excipients market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Europe dominated the global pharmaceutical excipients market in 2018 and the trend is expected to continue throughout the forecast period
  • The pharmaceutical excipients market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. Increase in demand for pharmaceuticals due to rise in population in Japan is expected to boost the pharmaceutical industry in the country, thereby driving the growth of the pharmaceutical excipients market.

Pharmaceutical Excipients Market: Major Players

Key players operating in the global pharmaceutical excipients market are

  • BASF SE
  • Colorcon Inc.
  • Ashland, Inc.
  • Croda International Plc
  • Roquette Frères
  • Evonik Industries AG
  • DuPont de Nemours, Inc.
  • Associated British Foods plc
  • Archer Daniels Midland Company
  • Lubrizol Corporation

These players are focused on adopting inorganic growth strategies to strengthen their product portfolio. These companies have adopted strategies such as partnerships and acquisitions to strengthen their market position; expand their portfolio of products; and expand their geographical presence.

More Trending Reports by Transparency Market Research –

Particle Therapy Market: The global particle therapy market is anticipated to exceed the value of US$ 1.2 Bn by 2031. The global market is projected to expand at a CAGR of 8.6% from 2022 to 2031.

Physician Dispensed Cosmeceuticals Market: The global physician dispensed cosmeceuticals market is expected to reach the value of US$ 19 Bn by the end of 2031.

Hernia Repair Devices Market: The global hernia repair devices market is expected to reach the value of US$ 8.62 Bn by the end of 2028.

Preventive Healthcare Technologies & Services Market: The global preventive healthcare technologies and services market is expected to reach the value of US$ 557.47 Mn by the end of 2028.

Coronary Stents Market: The global coronary stents market is expected to reach the value of US$ 25.7 Bn by the end of 2028.

Hyperbaric Oxygen Therapy Devices Market: The global hyperbaric oxygen therapy devices market is expected to reach the value of US$ 7.3 Bn by the end of 2028.

Glioblastoma Multiforme Treatment Market: The global glioblastoma multiforme (GBM) treatment market is expected to reach the value of US$ 3.72 Bn by the end of 2028.

Scar Treatment Market: The value of global scar treatment market size was clocked at US$ 15.08 Bn in 2018. The global scar treatment market is estimated to rise at a CAGR of 8.3% during the forecast period, from 2019 to 2027.

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

Blog: https://tmrblog.com

Email: sales@transparencymarketresearch.com